Simultaneous Estimation of Saxagliptin and Dapagliflozin in Human Plasma by Validated High Performance Liquid Chromatography - Ultraviolet Method
Sign Up to like & getrecommendations! Published in 2019 at "Turkish Journal of Pharmaceutical Sciences"
DOI: 10.4274/tjps.galenos.2018.46547
Abstract: Objectives: The fixed dose combination of saxagliptin and dapagliflozin is a recently approved antidiabetic medication. It is marketed under the brand name Qtern. The aim of this study was to develop a simple, rapid, sensitive,… read more here.
Keywords: human plasma; saxagliptin dapagliflozin; method; dapagliflozin human ... See more keywords